Estate Counselors LLC Purchases Shares of 9,920 Axon Enterprise, Inc $AXON

Key Points

• Estate Counselors LLC acquired a new position in Axon Enterprise, Inc valued at approximately $5.22 million, marking its 23rd largest holding and comprising about 0.5% of its investment portfolio.
• Axon Enterprise reported a 32.6% increase in revenue year-over-year and EPS of $2.12, surpassing the consensus estimate of $1.54.
• Wall Street analysts have set a consensus price target of $837.69, with thirteen analysts rating the stock as a "Buy" and two as "Hold".

Estate Counselors LLC bought a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 9,920 shares of the biotechnology company's stock, valued at approximately $5,217,000. Axon Enterprise comprises approximately 0.5% of Estate Counselors LLC's investment portfolio, making the stock its 23rd biggest position.

Other institutional investors and hedge funds have also modified their holdings of the company. TCTC Holdings LLC boosted its stake in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock worth $29,000 after acquiring an additional 24 shares during the last quarter. Fourth Dimension Wealth LLC purchased a new position in shares of Axon Enterprise during the 4th quarter worth $30,000. Bartlett & CO. Wealth Management LLC boosted its stake in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock worth $31,000 after acquiring an additional 33 shares during the last quarter. Catalyst Capital Advisors LLC purchased a new position in shares of Axon Enterprise during the 1st quarter worth $32,000. Finally, Alpine Bank Wealth Management purchased a new position in shares of Axon Enterprise during the 1st quarter worth $40,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of AXON traded up $2.73 during trading hours on Friday, reaching $766.24. 395,415 shares of the stock traded hands, compared to its average volume of 739,771. The company has a current ratio of 2.95, a quick ratio of 2.71 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52-week low of $346.71 and a 52-week high of $885.91. The company's 50-day moving average price is $773.05 and its two-hundred day moving average price is $674.00. The company has a market cap of $60.15 billion, a P/E ratio of 189.20, a price-to-earnings-growth ratio of 28.12 and a beta of 1.36.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million for the quarter, compared to analysts' expectations of $641.77 million. During the same quarter in the previous year, the company earned $1.20 EPS. Axon Enterprise's revenue for the quarter was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. On average, analysts anticipate that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on AXON shares. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the stock an "overweight" rating in a research note on Friday, July 11th. Northland Securities set a $800.00 price target on shares of Axon Enterprise in a research note on Tuesday, August 5th. Needham & Company LLC set a $870.00 target price on shares of Axon Enterprise and gave the company a "buy" rating in a research note on Tuesday, August 5th. JPMorgan Chase & Co. lifted their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a research note on Thursday, July 17th. Finally, JMP Securities lifted their target price on shares of Axon Enterprise from $725.00 to $825.00 and gave the company a "market outperform" rating in a research note on Tuesday, July 22nd. Thirteen analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $837.69.

Insider Buying and Selling

In other Axon Enterprise news, CAO Jennifer H. Mak sold 75 shares of Axon Enterprise stock in a transaction on Friday, June 13th. The shares were sold at an average price of $771.81, for a total value of $57,885.75. Following the sale, the chief accounting officer directly owned 15,240 shares in the company, valued at approximately $11,762,384.40. The trade was a 0.49% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of Axon Enterprise stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the completion of the sale, the chief executive officer owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. This represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,790 shares of company stock worth $33,654,451 in the last 90 days. 4.40% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.